Antifibrotic Therapies and Progressive Fibrosing Interstitial Lung Disease (PF-ILD): Building on INBUILD

Antifibrotic Therapies and Progressive Fibrosing Interstitial Lung Disease (PF-ILD): Building on INBUILD

Progressive fibrosing interstitial lung disease (PF-ILD) describes a phenotypic subset of interstitial lung diseases characterized by progressive, intractable lung fibrosis. PF-ILD is separate from, but has radiographic, histopathologic, and clinical similarities to idiopathic pulmonary fibrosis. Tw...

Full description

Bibliographic Details
Main Authors: John N. Shumar, Abhimanyu Chandel, Christopher S. King
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Journal of Clinical Medicine
Subjects:
progressive fibrosing interstitial lung disease
pulmonary fibrosis
pirfenidone
nintedanib
interstitial lung disease
IPF
Online Access:https://www.mdpi.com/2077-0383/10/11/2285

Internet

https://www.mdpi.com/2077-0383/10/11/2285

Similar Items